Appay, R., Dehais, C., Colin, C., Alentorn, A., Carpentier, C., Ducray, F., . . . Figarella-Branger, D. (2019). PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas. Neuro Oncol.
Chicago-стиль цитированияAppay, R., et al. "PL1.1 CDKN2A Homozygous Deletion Is a Strong Adverse Prognosis Factor in Diffuse Malignant IDHmutant Gliomas." Neuro Oncol 2019.
MLA-цитированиеAppay, R., et al. "PL1.1 CDKN2A Homozygous Deletion Is a Strong Adverse Prognosis Factor in Diffuse Malignant IDHmutant Gliomas." Neuro Oncol 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.